WhiteGlove Health, Inc., an Austin, TX-based medical care provider focused on lowering employer healthcare costs, has closed a $12.9m Series E funding.
The round, which was led by Burrill & Company, also includes an additional $15.3m of warrants over the next two years.
The company intends to use the funding to increase adoption in existing markets, and expand into new markets, as well as develop a broker/benefits consultant sales channel.
Led by co-founder and CEO Bob Fabbio, WhiteGlove Health offers a Corporate Membership Program, which gives employees and dependents access to acute care, preventative care, chronic care, diagnostics, and Rx medications 365 days a year, in-person (at home or work) or over-the-phone.
Under the program, employers pay for WhiteGlove memberships and WhiteGlove does not charge the employer’s health plan for its medical services or the generic Rx medications prescribed for its in-person visits.